Govorestat, First and Only Potential Treatment for Classic Galactosemia, Does Not Receive FDA Approval

Galactosemia Foundation Urges FDA to Reconsider on Behalf of Rare Disease Community Facing Devastating Disease ALBANY, N.Y., Nov. 27, 2024 /PRNewswire/ -- The Galactosemia Foundation, a non-profit charitable organization that advocates for people with Galactosemia and their families,...